Ganglioglioma classification: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
(Mahshid) |
||
| Line 19: | Line 19: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Revision as of 23:31, 26 November 2017
|
Ganglioglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ganglioglioma classification On the Web |
|
American Roentgen Ray Society Images of Ganglioglioma classification |
|
Risk calculators and risk factors for Ganglioglioma classification |
Overview
According to the World Health Organization (WHO) classification system, ganglioglioma may be classified into 3 grades based on the severity of disease and the degree of cellular differentiation.
Classification
According to the World Health Organization (WHO) classification system, ganglioglioma may be classified into the following 3 grades:[1]
- WHO Grade I: Well-differentiated, benign ganglioglioma with slow growth
- WHO Grade II: Benign ganglioglioma with less degree of differentiation compared to grade I
- WHO Grade III: Anaplasic, malignant ganglioglioma with rapid growth
References
- ↑ Pandita A, Balasubramaniam A, Perrin R, Shannon P, Guha A (2007). "Malignant and benign ganglioglioma: a pathological and molecular study". Neuro Oncol. 9 (2): 124–34. doi:10.1215/15228517-2006-029. PMC 1871674. PMID 17259542.